TCRT
Alaunos Therapeutics, Inc.
0.07
USD
This page is just a preview of the data found in TrendSpider’s full version
Alaunos Therapeutics, Inc. stock is down -17% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 36.84% of the previous 18 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 PUT.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 20 Oct 15:27 | 19 Apr, 2024 | 2.50 | 0 |
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR. The company was formerly known as ZIOPHARM Oncology, Inc.
